AtriCure ATRC Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | ||||||
| Appendage management | $63.99M+14.4% | $60.01M+15.9% | $56.89M+14.7% | $55.62M+20.9% | $55.91M+20.2% | |
| Minimally invasive ablation | $8.05M-21.2% | $8.3M-20.9% | $9.85M-24.3% | $9.29M-27.4% | $10.21M-24.9% | |
| Open ablation | $52.13M+11.3% | $48.6M+14.9% | $49.32M+17.4% | $46.44M+18.5% | $46.82M+17.2% | |
| Pain management | $29.44M+26.9% | $24.35M+27.8% | $24.44M+24.4% | $22.92M+28.0% | $23.2M+42.8% | |
| Revenue from Contract with Customer, Excluding Assessed Tax by Geography | ||||||
| Asia Pacific | $8.63M+15.4% | $7.08M+4.3% | —— | —— | $7.48M+9.3% | |
| Europe | $17.21M+6.7% | $16.07M+13.2% | $15.99M+16.9% | $15.17M+24.2% | $16.13M+27.7% | |
| Other International | $2.17M+12.1% | $1.89M+27.2% | $1.8M+15.8% | $1.71M+28.6% | $1.94M+40.6% | |
| United States | $125.59M+13.6% | $116.21M+14.9% | $114.33M+12.6% | $109.31M+14.5% | $110.58M+15.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AtriCure break its business down?
- AtriCure (ATRC) reports revenue from contract with customer, excluding assessed tax by product across 4 parts — Appendage management, Minimally invasive ablation, Open ablation and Pain management. Each is extracted from the segment footnotes and tracked over time.
- Where does AtriCure's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AtriCure's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
